Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2- primary breast cancer. This is an ASCO Meeting Abstract from the 2014 Breast Cancer Symposium. This abstract does not include a full ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果